25-hydroxycholesterol has been researched along with Papillomavirus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, C; Jiang, S; Li, B; Lu, L; Sha, Y; Sui, L; Tian, P; Wang, Q; Zhang, L | 1 |
| Biasi, F; Cagno, V; Civra, A; Donalisio, M; Lembo, D; Leonarduzzi, G; Poli, G | 1 |
2 other study(ies) available for 25-hydroxycholesterol and Papillomavirus Infections
| Article | Year |
|---|---|
25-hydroxycholesterol inhibits human papillomavirus infection in cervical epithelial cells by perturbing cytoskeletal remodeling.
Topics: Animals; Epithelial Cells; Female; Human Papillomavirus Viruses; Humans; Mice; Papillomavirus Infections; Uterine Cervical Neoplasms | 2023 |
Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol.
Topics: Animals; Antiviral Agents; Cell Proliferation; Cells, Cultured; Human papillomavirus 16; Humans; Hydroxycholesterols; Papillomavirus Infections; Picornaviridae Infections; Rhinovirus; Rotavirus; Rotavirus Infections; Virus Inactivation | 2014 |